FDA – Comments submitted to FDA on Establishment of the Patient Engagement Advisory Committee

Regulatory Comments

Comments submitted to FDA on Establishment of the Patient Engagement Advisory Committee. (Docket Number: FDA-2015-N-3166).

read the comments

Related

FDA – Comments submitted regarding Public Notification of Emerging Postmarket Medical Device Signals (“Emerging Signals”)

FDA – Comments submitted regarding Clinical Outcome Assessment Compendium

CIOMS – Comments submitted regarding the public consultation on the Revision of CIOMS 2002 International Ethical Guidelines for Biomedical Research Involving Human Subjects